- PR Newswire•last month
CLEVELAND, Jan. 9, 2017 /PRNewswire/ -- DATATRAK International, Inc. (DTRK), has solidified its commitment to its European clients by being one of the first 1,400 U.S. corporations to self-certify its compliance with the new EU-U.S. Privacy Shield Framework. The Privacy Shield Framework was instituted to replace the prior U.S.-EU Safe Harbor Framework, and was approved on July 12, 2016 by the European Commission to adequately enable secure data transfers under U.S. and EU law. DATATRAK also maintains its certification with its sister policy – the U.S.-Swiss Safe Harbor Framework, which still remains in effect.
- PR Newswire•3 months ago
CLEVELAND, Nov. 28, 2016 /PRNewswire/ -- DATATRAK International, Inc. (DTRK), has released their innovative clinical trial management system, CTMS 360°. DATATRAK's CTMS is a robust, cloud-based, SaaS platform that will allow you to leverage your clinical study data with a top-of-class CTMS solution that seamlessly accesses data in real-time to provide the most current study status updates possible. "Our first priority was to make sure that CTMS 360° was able to adapt to the needs of the user, not the user adapting to the platform," says Jim Bob Ward, CEO of DATATRAK.
- Capital Cube•4 months agoDATATRAK International, Inc. :DTRK-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016
Categories: Yahoo Finance Get free summary analysis DATATRAK International, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of DATATRAK International, Inc. – Veeva Systems Inc Class A and Medidata Solutions, Inc. (VEEV-US and MDSO-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more (Read more...)
DTRK : Summary for DATATRAK INTL INC - Yahoo Finance
DATATRAK International, Inc. (DTRK)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||25.00|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|